In animal studies, high glucocorticoid levels increase beta-amyloid (Aβ) deposition and tau pathology4,5, as well as neuronal loss in AD-vulnerable areas rich in glucocorticoid receptors (GR), such as medial temporal lobes and frontal cortex6–9. Here, NR3C1 is linked to Alzheimer disease.